TABLE 2. Difference in proportion of bacteriologically confirmed* TB cases before and after Xpert MTB/RIF installation, and Bootstrap mean difference estimates and 95% CIs for treatment outcomes, by health facility (N = 6) — Kampala, Uganda, 2012 – 2015.
| Characteristics | Health facility |
|||||
|---|---|---|---|---|---|---|
| Alive Medical Services | Kisenyi Health Center IV | Kisugu | Mengo | Mulago Ward 5 and 6 | Nsambya Hospital | |
| Difference in proportion of bacteriologically confirmed* TB cases %, (95% CI) |
8.3 (−3.1 to 29.8) |
30.8 (21.3 to 40.2)† |
14.9 (−3.8 to 33.3) |
−10.1 (−26.3 to 6.3) |
−1.7 (−12.6 to 9.3) |
5.1 (−14.0 to 24.2) |
|
Bootstrap mean difference estimates (95% CI)§ for TB treatment outcomes
| ||||||
| TB treatment completed |
−0.119 (−0.357 to 0.119) |
0.184 (0.059 to 0.307)† |
−0.153 (−0.364 to 0.056) |
−0.012 (−0.130 to 0.097) |
−0.064 (−0.169 to 0.040) |
−0.728 (−0.839 to −0.598) |
| Stopped TB treatment before completion |
0.000 (−0.214 to 0.214) |
−0.179 (-0.292 to 0.063)† |
0.071 (−0.105 to 0.249) |
0.040 (−0.056 to 0.149) |
0.030 (−0.063 to 0.125) |
−0.018 (−0.134 to 0.098) |
| Continuing TB treatment | 0.119 (−0.048 to 0.298) | −0.006 (−0.081 to 0.074) | 0.082 (−0.051 to 0.233) | −0.028 (−0.079 to 0.031) | 0.034 (−0.031 to 0.102) | 0.746 (0.608 to 0.866)† |
Abbreviations: CI = confidence intervals; TB = tuberculosis.
* Bacteriologically confirmed TB includes cases diagnosed using either GenXpert or culture.
† Statistically significant (p≤0.05).
§ Bootstrap percentile CIs using 100,000 samples per model.